Patent Assignment
Reel/Frame 012698/0406
Change of Name
Recorded: 2002-03-11
Pages: 3
Assignor
CENTEON L.L.C.
Executed: 1999-12-22
Assignee
AVENTIS BEHRING L.L.C.
1020 FIRST AVENUE, KING OF PRUSSIA, PENNSYLVANIA, 19406
Covered Properties
(4)
Fusion Polypeptides Comprising Human Serum Albumin,Nucleic Acids Encoding Same,and Recombinant Expression Thereof
Patent:
5,876,969 →
Application:
08/797,689 →
Albumin Derivatives with Therapeutic Functions
Patent:
6,165,470 →
Application:
09/004,319 →
Albumin derivatives with therapeutic functions
Application:
09/551,635 →
Fusion Polypeptides of Human Serum Albumin and a Therapeutically Active Polypeptide
Related Assignments
(11)
Other recorded transfers of the patents in this record — the chain of ownership.
Contract
Mar 1, 2002
From: RHONE-POULENC RORER S.A.
To: CENTEON L.L.C.
Reel/Frame 012653/0458 →
Corrective Assignment to Correct the Patent Number from 6-154,470 to 6,165,470. Document Previously Recorded at Reel 012653 Frame 0458.
Jun 5, 2002
From: RHONE-POULENC RORER S.A.
To: CENTEON L.L.C.
Reel/Frame 012973/0152 →
Assignment of Assignor's Interest
Jul 11, 2006
From: AVENTIS BEHRING L.L.C.
To: DELTA BIOTECHNOLOGY LTD.
Reel/Frame 017921/0492 →
Change of Name
Dec 31, 2007
From: NOVOZYMES DELTA LIMITED
To: NOVOZYMES BIOPHARMA UK LIMITED
Reel/Frame 020299/0491 →
Change of Name
Dec 31, 2007
From: DELTA BIOTECHNOLOGY LIMITED
To: NOVOZYMES DELTA LIMITED
Reel/Frame 020299/0814 →
Corrective Assignment to Correct the U.S. Patent No. 6,686,179 Was Erroneously Typed as U.S. Patent No. 6,684,179 Previously Recorded on Reel 017921 Frame 0492. Assignor(S) Hereby Confirms the Change of Name.
May 30, 2008
From: AVENTIS BEHRING L.L.C.
To: DELTA BIOTECHNOLOGY LIMITED
Reel/Frame 021018/0510 →
Corrective Assignment to Correct the U.S. Patent No. 6,686,179 Was Erroneously Typed as U.S. Patent No. 6,684,179 Previously Recorded on Reel 020299 Frame 0814. Assignor(S) Hereby Confirms the Change of Name.
May 30, 2008
From: DELTA BIOTECHNOLOGY LIMITED
To: NOVOZYMES DELTA LIMITED
Reel/Frame 021018/0534 →
Corrective Assignment to Correct the U.S. Patent No. 6,686,179 Was Erroneously Typed as U.S. Patent No. 6,684,179 Previously Recorded on Reel 020299 Frame 0491. Assignor(S) Hereby Confirms the Change of Name.
May 30, 2008
From: NOVOZYMES DELTA LIMITED
To: NOVOZYMES BIOPHARMA UK LIMITED
Reel/Frame 021018/0539 →
Assignment of Assignor's Interest
Oct 7, 2010
From: NOVOZYMES BIOPHARMA UK LIMITED
To: NOVOZYMES BIOPHARMA DK A/S
Reel/Frame 025105/0517 →
Change of Name
Aug 25, 2011
From: DELTA BIOTECHNOLOGY LIMITED
To: NOVOZYMES BIOPHARMA UK LIMITED
Reel/Frame 026808/0549 →
Assignment of Assignor's Interest
Aug 26, 2011
From: NOVOZYMES BIOPHARMA UK LIMITED
To: NOVOZYMES BIOPHARMA DK A/S
Reel/Frame 026813/0938 →